3D-QSAR STUDY OF MALEIMIDE ANALOGUES AS GLYCOGEN SYNTHASE KINASE-3 (GSK-3) INHIBITORS USING CoMSIA APPROACH

被引:0
作者
Crisan, Luminita [1 ]
Avram, Sorin [1 ]
Bora, Alina [1 ,2 ]
Kurunczi, Ludovic [1 ,3 ]
Pacureanu, Liliana [1 ]
机构
[1] Roumanian Acad, Inst Chem, Dept Computat Chem, Timisoara 300223, Romania
[2] West Univ Timisoara, Dept Chem, Fac Chem Biol Geog, Timisoara 300115, Romania
[3] Victor Babes Univ Med & Pharm, Timisoara 300041, Romania
关键词
3D QSAR; COMSIA; maleimide; MOLECULAR SIMILARITY INDEXES; BIOLOGICAL EVALUATION; SELECTIVE INHIBITORS; POTENT; BINDING; DESIGN; OPTIMIZATION; DERIVATIVES; DISCOVERY; AGENTS;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Several series of substituted maleimide derivatives (3-anilino-4-aryl, indolyl, oxaindolyl), and macrocyclic maleimides were reported as potent, selective GSK-3 inhibitors. In order to gain overall insight into structural prerequisites that influence biological activity, we adopted a ligand-based methodology - three-dimensional quantitative structure activity relationships which has been developed using the Field Based QSAR module from Schrodinger suite and a large collection of maleimide compounds (203). The CoMSIA model which was generated based on training set and validated on test set compounds (R-train(2)=0.833, Q(train)(2)=0.673, R-Pearson test=0.832) is reliable and can be used to predict novel inhibitors of GSK-3 belonging to the same structural class. The molecular structural features and field contour maps portrayed by 3D-QSAR model afforded relevant insights into the structure activity profile of maleimide derivatives. The CoMSIA model, confirm the experimental interaction pattern and is helpful for future lead compound optimization, design and prioritization of new inhibitors for chemical synthesis.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 39 条
[1]   Novel and versatile methodology for synthesis of cyclic imides and evaluation of their cytotoxic, DNA binding, apoptotic inducing activities and molecular modeling study [J].
Abdel-Aziz, Alaa A. -M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2007, 42 (05) :614-626
[2]   Synthesis and biological evaluation of novel indolocarbazoles with anti-angiogenic activity [J].
Acero, Nuria ;
Brana, Miguel F. ;
Anorbe, Loreto ;
Dominguez, Gema ;
Munoz-Mingarro, Dolores ;
Mitjans, Francesc ;
Piulats, Jaume .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 48 :108-113
[3]  
[Anonymous], 2014, FIELD BAS QSAR VERS
[4]  
[Anonymous], LIGPREP VERS 2 9
[5]  
[Anonymous], 2014, MAESTR VERS 9 7
[6]  
[Anonymous], 2010, ROCS VERS 3 1 0
[7]   Synthesis and evaluation of hexahydropyrrolo[3,4-d]isoxazole-4,6-diones as anti-stress agents [J].
Badru, Rahul ;
Anand, Preet ;
Singh, Baldev .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 48 :81-91
[8]   Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa [J].
Böhm, M ;
Stürzebecher, J ;
Klebe, G .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (03) :458-477
[9]   Inhibition of Bfl-1 with N-aryl maleimides [J].
Cashman, John R. ;
MacDonald, Mary ;
Ghirmai, Senait ;
Okolotowicz, Karl J. ;
Sergienko, Eduard ;
Brown, Brock ;
Garcia, Xochella ;
Zhai, Dayong ;
Dahl, Russell ;
Reed, John C. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) :6560-6564
[10]   Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer's disease and other neurodegenerative disorders [J].
Castro, A ;
Martinez, A .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (10) :1519-1527